Patents by Inventor NICHOLAS M. KANAAN

NICHOLAS M. KANAAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method for preventing or treating a tauopathy
    Patent number: 9862761
    Abstract: The present invention is a composition and method for the prevention and treatment of a tauopathy. The composition of the invention includes N-terminal amino acid residues of the tau protein, which have been identified as being involved in toxic activation of a PP1/GSK3 signaling cascade and inhibition of fast axonal transport in human tauopathies.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: January 9, 2018
    Assignees: The Board of Trustes of the University of Illinois, Northwestern University
    Inventors: Scott Thomas Brady, Lester I. Binder, Gerardo Andres Morfini, Nicholas M. Kanaan, Nichole E. LaPointe
  • Composition and method for treating a tauopathy
    Patent number: 9605054
    Abstract: The present invention is a composition and method for the prevention and treatment of a tauopathy. The composition of the invention includes N-terminal amino acid residues of the tau protein, which have been identified as being involved in toxic activation of a PP1/GSK3 signaling cascade and inhibition of fast axonal transport in human tauopathies.
    Type: Grant
    Filed: October 18, 2010
    Date of Patent: March 28, 2017
    Assignees: The Board of Trustees of the University of Illinois, Northwestern University
    Inventors: Scott T. Brady, Lester I. Binder, Gerardo Andres Morfini, Nicholas M. Kanaan, Nichole E. LaPointe
  • COMPOSITION AND METHOD FOR PREVENTING OR TREATING A TAUOPATHY
    Publication number: 20160031978
    Abstract: The present invention is a composition and method for the prevention and treatment of a tauopathy. The composition of the invention includes N-terminal amino acid residues of the tau protein, which have been identified as being involved in toxic activation of a PP1/GSK3 signaling cascade and inhibition of fast axonal transport in human tauopathies.
    Type: Application
    Filed: September 24, 2015
    Publication date: February 4, 2016
    Inventors: Scott Thomas Brady, Lester I. Binder, Gerardo Andres Morfini, Nicholas M. Kanaan, Nichole E. LaPointe
  • Composition and Method for Preventing or Treating a Tauopathy
    Publication number: 20120142602
    Abstract: The present invention is a composition and method for the prevention and treatment of a tauopathy. The composition of the invention includes N-terminal amino acid residues of the tau protein, which have been identified as being involved in toxic activation of a PP1/GSK3 signaling cascade and inhibition of fast axonal transport in human tauopathies.
    Type: Application
    Filed: October 18, 2010
    Publication date: June 7, 2012
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventors: SCOTT T. BRADY, LESTER I. BINDER, GERARDO ANDRES MORFINI, NICHOLAS M. KANAAN, Nichole E. LaPointe